3SBio ties up with Ascentage Pharma to develop and commercialize cancer therapeutics
Research and Development
Monday, 15 February 2010 18:00
3SBio Inc, a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, and Ascentage Pharma Group Corporation, Ltd have formed a strategic alliance to research, develop and commercialize best-in-class targeted cancer therapeutics focusing on programmed cell death, or apoptosis.
Cadila Pharmaceuticals’ plan to indigenously develop Influenza A HINI (swine flu) vaccine in collaboration with US-based Novavax is likely to be delayed as the government has shown caution in giving go-ahead for the clinical trials.
Pharma major Dr Reddy’s Laboratories Ltd., (DRL), on Monday, announced results from the first phase III trials of its chemical entity, Balaglitazone, an insulin sensitizer used in the treatment of diabetes.
TCG Lifesciences, the Rs 400-crore clinical research organisation (CRO) venture of the Chatterjee Group, has entered into an exclusive collaboration with the US-based pharma giant, Pfizer, to develop a portfolio of pre-clinical molecules for discovery of new drugs.